JeffreyDerrickWhiteMD

PubMed

• 54 citations
  Reduction in HTLV‐I proviral load and spontaneous lymphoproliferation in HTLV‐I–associated myelopathy/tropical spastic paraparesis patients treated with humanized anti...
  Tanya J. Lehky, Michael C. Levin, Ryuji Kubota, Richard N. Bamford, Alfred N. Flerlage
  Annals of Neurology. 1998-12-01
• 58 citations
  Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment
  David A. Wheeler, Naoko Takebe, Toshinori Hinoue, Katherine A. Hoadley, Maria F. Cardenas
  Cancer Cell. 2021-01-11
• 35 citations
  The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous o...
  Michael Cullen, Robert Huddart, Johnathan Joffe, Deborah Gardiner, Lauren Maynard
  European Urology. 2020-03-01

Journal Articles

• Proceedings of the Indo-US bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment and survival  
  Kumar NB, Dhurandhar M, Aggarwal B, Anant S, Kenyon D, Deng G, Djeu J, Dou, J, Hawk E, Jayaram B, Jia L, Joshi R, Karkarala M, Karunagaran D, Kucuk O, Kumar L, Malafa ..., Cancer Medicine, 1/1/2013
• The National Cancer Institute Best Case Series Program: A Summary of Cases of Cancer Patients Treated With Unconventional Therapies in India  
  Olaku O, Zia F, Santana JM, and White JD, Integr Cancer Ther, 1/1/2013
• Systematic Review: Generating Evidence-based Guidelines on the Concurrent Use of Dietary Antioxidants and Chemotherapy or Radiotherapy  
  Nakayama A, Alladin KP, Igbokwe O, White JD, Cancer Investigation, 1/1/2011
• Herbal Therapy Use by Cancer Patients: A Literature Review on Case Reports  
  Olaku O, White JD, Eur J Cancer, 1/1/2011
• Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment  
  Wang E, Bussom S, Chen J, Quinn C, Bedognetti D, Lam W, Guan F, Jiang Z, Mark Y, Zhao Y, Stroncek DF, White J, Marincola FM and Cheng YC, BMC Medical Genomics, 1/1/2011
• Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells  
  Volate SR, Kawasaki BT, Hurt EM, Milner JA, Kim YS, White J, Farrar WL, Mol Cancer Ther, 1/1/2010
• Encyclopedia of Dietary Supplements  
  White JD, 1/1/2010
• The Challenge of Rational Development of Complex Natural Products as Cancer Therapeutics  
  White J, J Natl Cancer Inst, 1/1/2010
• National Cancer Institute Best Case Series Program  
  Zia FZ, White JD, Integr Cancer Ther, 1/1/2009
• Survey of CAM Practitioners Regarding Cancer Management and Research  
  Lee CO, Zia FZ Olaku O, White JD, Journal of the Society for Integrative Oncology, 1/1/2009
• Survey of Cancer Researchers Regarding Complementary and Alternative Medicine  
  Smith WB, Olaku O, Michie J, White JD, Journal of the Society for Integrative Oncology, 1/1/2008
• Preclinical and phase I clinical trial of blockade of IL-15 using Mik beta1 monoclonal antibody in T cell large granular lymphocyte leukemia  
  Morris JC, Janik JE, White JD, Fleisher TA, Brown M, Tsudo M, Goldman CK, Bryant B, Petrus M, Top L, Lee CC, Gao W, Waldmann TA, Proc Natl Acad Sci USA, 1/1/2006
• Exceptional Disease Courses After the Use of Complementary and Alternative Medicine  
  Launso L, Drageset BJ, Fonnebo V, Jacobsen JS, Haahr N, White JD, Egeland E, Salamonsen A, Horneber M, Journal of Alternative and Complementary Medicine, 1/1/2006
• Encyclopedia of Dietary Supplements  
  White JD, 1/1/2005
• Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical ...  
  Buchanan DR, White JD, O'Mara AM, Kelaghan JW, Smith WB, Minasian LM, J Clin Oncol, 1/1/2005
• PC SPES – a lesson for future dietary supplement research  
  White, JD, J Natl Cancer Inst, 1/1/2002
• Cancer: current research in alternative therapies  
  White, JD, Primary Care, 1/1/2002
• The National Cancer Institute's Perspective and Agenda for Promoting Awareness and Research on Alternative Therapies for Cancer  
  White, JD, J Altern Complement Med, 1/1/2002
• Asian therapies for cancer-coming of age  
  Chang R, White JD, J Altern Complement Med, 1/1/2002
• Complementary and alternative medicine research: a National Cancer Institute perspective  
  White JD, Semin Oncol, 1/1/2002
• Treatment of Epidermolysis Bullosa Acquisita with the Humanized anti-Tac mAb Daclizumab  
  Egan CA, Brown M, White JD, Yancey KB, Clin Immunol, 1/1/2001
• The Combination of Zidovudine and Interferon Alpha-2b in the Treatment of Adult T-cell Leukemia/Lymphoma  
  White JD, Wharfe G, Stewart DM, Maher VE, Eicher D, Herring B, Derby M, Jackson-Booth P, Cranston B, Hanchard B, Lee CC, Top TE, Fleisher TA, Nelson DL, Waldmann TA, Leukemia & Lymphoma, 1/1/2001
• Complementary and alternative medicine in cancer: a National Cancer Institute perspective  
  Smith WB, White JD, Expert Opinion on Biological Therapy, 1/1/2001
• Gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study  
  Toro JR, Beaty M, Sorbara L, Turner ML, White J, Kingman DW, Raffeld M, Jaffe E., Archives of Dermatology, 1/1/2000
• Cancer clinical trials and subject utilization of natural herbal products: A Case Study  
  Sparber A, Jonas W, White J, Derenzo E, Johnson E, Bergerson S, Cancer Investigation, 1/1/2000
• Join now to see all

Books/Book Chapters

• Abeloff's Clinical Oncology 
  Chapter: Complementary and Alternative Medicine. 
  John E. Niederhuber, MD; James O. Armitage, MD; James H. Doroshow, MD; Michael B. Kastan, PhD; and Joel Tepper, MDElsevier, Inc.Edition 5th,2013
• Cancer: Principles and Practice of Oncology 
  Chapter: Complementary, Alternative and Unproven Methods of Cancer Treatment. 
  White JDEditors: V. T. DeVita, S. Hellman, S.A. Rosenberg.Edition 6th,2001

Abstracts/Posters

• Complementary and alternative medicine use by Hispanic cancer patients and the impact of acculturation: National Health Interview Survey 2007.
  Santana J, Olaku O, White J, Zia F, 139th APHA Annual Meeting (Alternative and Complementary Health Practices), 1/29/2011
• Yttrium-90 Radiolabeled Daclizumab, an Anti-CD25 Monoclonal Antibody, Provides Effective Therapy for Refractory and Relapsed Hodgkin's Lymphoma.
  Janik JE, Morris JC, Conlon KC, O'Mahony D, Pittaluga S, Jaffe ES, Brechbiel MW, Paik CH, Whatley M, Fleisher TA, White JD, Steward DM, Fioravanti S, Lee CC, Goldman C..., American Society of Hematology Annual Meeting, 1/1/2011
• Effects of stress on cancer treatment effectiveness: a literature review of animal models.
  Kawa S and White JD, American Psychosomatic Society 68th Annual Scientific Meeting, Portland, OR, 1/10/2010
• Traditional Chinese Medicine, Systems Biology and System Medicine.
  Xi, D and White JD, The Society for Integrative Oncology, Shanghai International Symposium: Integrative Oncology Theory, Research, and Practice, Shanghai, China, 1/1/2008
• Phase I trial of recombinant immunotoxin anti-Tac (Fv)-PE38 (LMB-2) in patients with hematologic malignancies.
  Kreitman RJ, Wilson W, Waldmann TA, White JD, Pearson D, Dyer V, Margulies I, Stetler-Stevenson MA, Pastan I, Blood, 1/1/1998
• Responses in patients with hairy cell leukemia to recombinant immunotoxin anti-Tac (Fv)-PE38 (LMB-2).
  Kreitman RJ, Wilson W, Waldmann TA, White JD, Pearson D, Dyer V, Margulies I, Robbins D, Stetler-Stevenson MA, Pastan I., Blood, 1/1/1998
• Phase I clinical trial of recombinant immunotoxin anti-Tac (Fv)-PE38 (LMB-2) in patients with hematologic malignancies.
  Kreitman RJ, White JD, Pearson D, Top LE, Waldmann TA, Pastan I, Blood, 1/1/1997
• Biodistribution of In-111 vs Y-90 labeled anti-Tac moncolonal antibody.
  Carrasquillo JA, White JD, Paik CH, Le N, Rotman M, Goldman CK, Brechbiel MW, Gansow OA, Top LE, Reynolds JC, Nelson DL, Waldmann TA, Journal of Nuclear Medicine, 1/1/1996
• The treatment of HAM/TSP patients with humanized anti-Tac antibody: preliminary immunologic studies.
  Lehky TJ, Levin M, Flerlage N, White J, Fleisher T, McFarland H, Waldmann T, Jacobson S, HTLV, Institut Pastuer, Paris, France, 1/17/1995
• Treatment of IL-2R expressing leukemia/lymphoma with monoclonal antibodies armed with yttrium-90.
  Waldmann TA, White JD, Antibody Immunoconjugates, and Radiopharmaceuticals, 1/1/1995
• Clinical uses of monoclonal antibodies.
  White JD, Paediatr Paedol, 1/1/1993
• Synchronous occurrence of T-helper cell mycosis fungoides (MF) and B-cell chronic lymphocytic leukemia (CLL).
  Quinones AR, Nam MH, White JD, Nigra TA, McKinley-Grant L, Pierce LE, Blood, 1/1/1991
• Join now to see all

Lectures

• Prevention and Treatment on Cancer in Integrative Medicine. 
  Tokyo, Japan - 1/17/2012
• Nutraceuticals, Herbs, and Society. 
  Georgetown University Medical Center - 1/12/2012
• President's Cancer Panel: America's Demographic and Cultural Transformation Implications for the Cancer Enterprise. 
  Miami, FL - 1/2/2010
• Fraudulent Cancer Cures: Medical and Legal Regulation of 'Cancer Treatment' 
  1/7/2009
• Controversies about Complementary and Alternative Medicine (CAM) in Oncology. 
  1/2/2006
• Complementary and Alternative Medicine in Cancer: Research and Practice 
  Siteman Cancer Center, Washington University, St. Louis, MO - 1/1/2001
• Keynote Address, Integrative Cancer Care: An Update from the Experts 
  Rochester, MN - 1/1/2000
• When Your Patient Asks About Alternative Medicine 
  Stanford University, Palo Alto, CA - 1/1/1998
• Join now to see all

Other

• National Cancer Institute's Support of Research to Further Integrative Oncology Practice. 
  White JD, JNCI Monographs
  1/1/2014
• New Trend in Cancer Therapy 
  White JD, Hodo Tokushu (News Special), TBS News
  Tokyo, Japan - 1/16/2004